Financial Performance - Fourth quarter total revenues reached $1.2 billion, with home sales revenues totaling $1.1 billion[6] - Fourth quarter net income was $36.0 million, or $1.21 per diluted share, while adjusted net income was $47.1 million, or $1.59 per diluted share[6] - Full year 2025 total revenues amounted to $4.1 billion, with home sales revenues of $3.9 billion[10] - Full year 2025 net income was $147.6 million, or $4.86 per diluted share, with adjusted net income of $181.7 million, or $5.99 per diluted share[10] - Adjusted net income for Q4 2025 was $47,101, compared to $113,596 in Q4 2024, a decrease of 58.6%[35] - Adjusted diluted earnings per share (EPS) for Q4 2025 was $1.59, down from $3.54 in Q4 2024, a decline of 55.1%[35] - The company reported a net income of $35,956 for Q4 2025, compared to $102,741 in Q4 2024, a decrease of 65.0%[35] - Net income for Q4 2025 was $35,956, a decline of 65.0% compared to $102,741 in Q4 2024[42] - EBITDA for Q4 2025 decreased by 52.6% to $75,884 from $160,174 in Q4 2024[42] - Adjusted EBITDA for Q4 2025 was $97,352, down 47.2% from $184,502 in Q4 2024[42] Home Sales and Deliveries - Total residential units delivered in the fourth quarter were 3,435, including 3,030 new homes[4] - The average sales price of new home deliveries for the fourth quarter was $366,700, while for the full year it was $378,000[6][10] - Total new home contracts for 2025 were 10,326, a decrease of 3.3% from 10,676 in 2024[27] - Average sales price for homes delivered in 2025 was $378.0 thousand, down 3.3% from $390.9 thousand in 2024[27] - The number of new home deliveries in Q4 2025 was 3,030, down 5.3% from 3,198 in Q4 2024[27] - Home sales revenues for Q4 2025 were $1,111,045, a decrease of 10.9% from $1,246,697 in Q4 2024[39] Inventory and Assets - Lot inventory decreased from 80,632 in 2024 to 60,916 in 2025, a decline of 24.5%[31] - Backlog of homes as of December 31, 2025, was valued at $283,725 thousand, a decrease of 19.2% from $351,162 thousand in 2024[30] - Total assets decreased from $4,532,472 in 2024 to $4,459,895 in 2025, a decline of 1.6%[25] - Total liabilities decreased from $1,911,616 in 2024 to $1,868,163 in 2025, a decline of 2.3%[25] Shareholder Returns and Equity - The company repurchased 333,881 shares of common stock for $20.0 million in the fourth quarter and 2,267,723 shares for $143.6 million over the full year, returning a record $178 million to stockholders[14] - As of December 31, 2025, the company had a book value per share of $89.21, a company record[13] - The company reported a total stockholders' equity of $2,591,732 in 2025, slightly down from $2,620,856 in 2024[47] Margins and Debt - Homebuilding gross margin for the fourth quarter was 15.4%, with an adjusted gross margin of 18.3%[8] - Adjusted homebuilding gross margin excluding inventory impairment for Q4 2025 was $182,415, representing 16.4%, down from 21.2% in Q4 2024[39] - The adjusted homebuilding gross margin excluding interest, inventory impairment, and purchase price for 2025 was $781,661, or 19.9%, compared to 23.3% in 2024[39] - Total homebuilding debt decreased to $1,063,607 in 2025 from $1,140,973 in 2024[47] - The ratio of net homebuilding debt to net capital improved to 25.9% in 2025 from 27.4% in 2024[47] - Inventory impairment increased by 59.0% in Q4 2025 to $10,865 compared to $6,835 in Q4 2024[42]

1 2025 Key Initiatives: Guidance and Outlook: 2 SOUTHWEST AIRLINES REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS; EXPECTS STRONG 2026 FINANCIAL PERFORMANCE FROM BUSINESS TRANSFORMATION 2025 net income $441 million / $0.79 EPS; adjusted net income $512 million / $0.93 adjusted EPS 2025 adjusted EBIT $574 million and above prior guidance of $500 million Guiding 2026 adjusted EPS of at least $4.00, up more than 300% over 2025 Ranked #1 in The Wall Street Journal Best U.S. Airlines of 2025 2026 guidance and ...

Financial Performance - Consolidated net sales for Q2 FY2026 were $149.9 million, down from $157.3 million in the prior year[3] - Adjusted operating income was $13.5 million, with an adjusted operating margin of 9.0%, down from 11.5% in the prior year[3] - Diluted EPS for the quarter was $0.46, with adjusted diluted EPS at $0.44, compared to $0.59 in the prior year[3] - Net sales for the three months ended December 31, 2025, were $149.916 million, a decrease of 4.7% compared to $157.260 million for the same period in 2024[21] - Operating income for the three months ended December 31, 2025, was $14.228 million, a decrease of 21.6% from $18.157 million in 2024[25] - Net income for the six months ended December 31, 2025, was $22.195 million, down 25.3% from $29.723 million in 2024[25] - Adjusted diluted EPS for the three months ended December 31, 2025, was $0.44, a decrease of 25.4% compared to $0.59 in 2024[25] - The company reported a GAAP operating margin of 9.5% for the three months ended December 31, 2025, compared to 11.5% in 2024[25] - Adjusted operating income for the three months ended December 31, 2025, was $13.468 million, a decline of 25.8% from $18.163 million in 2024[25] Cash and Investments - Total cash and investments at the end of the quarter were $179.3 million, with no outstanding debt[5][11] - Total current assets as of December 31, 2025, were $312.043 million, slightly up from $309.933 million as of June 30, 2025[22] - Total liabilities decreased to $236.683 million as of December 31, 2025, from $254.830 million as of June 30, 2025[22] - Shareholders' equity as of December 31, 2025, was $478.083 million, down from $482.269 million as of June 30, 2025[22] Sales and Orders - Written orders in the retail segment decreased by 17.9%, while wholesale segment written orders fell by 19.3%[3] - Customer deposits from undelivered written orders totaled $63.6 million, down from $75.1 million at the end of the previous quarter[10] Expenses and Dividends - Marketing expenses increased by 25.2% to $4.9 million, representing 3.2% of consolidated net sales[3] - A regular quarterly cash dividend of $0.39 per share was declared, payable on February 25, 2026[12] Workforce - The company operates 172 retail design centers, with a total headcount of 3,149, which is 5.1% lower than a year ago[8] Gross Margin - Gross margin improved to 60.9%, compared to 60.3% in the prior year[3] - Gross profit for the six months ended December 31, 2025, was $181.469 million, down from $188.706 million in 2024, reflecting a decline of 3.8%[21]

For additional information, contact: Derek Shelnutt EVP & Chief Financial Officer 229-426-6000, extension 6119 COLONY BANKCORP REPORTS FOURTH QUARTER 2025 RESULTS INCREASES QUARTERLY CASH DIVIDEND TO $0.12 PER SHARE FITZGERALD, GA. (January 28, 2026) – Colony Bankcorp, Inc. (NYSE: CBAN) ("Colony" or the "Company") today reported financial results for the fourth quarter of 2025. Financial highlights are shown below. Financial Highlights: The Company also announced that on January 28, 2026, the Board of Direc ...

Sales Performance - Sales for the three months ended December 28, 2025, were $244.1 million, an increase of $17.9 million, or 8%, compared to $226.2 million in the same period a year ago[74]. - Sales for the nine months ended December 28, 2025, were $817.8 million, an increase of $88.7 million, or 12%, from $729.1 million in the same period a year ago[88]. - Water Treatment segment sales increased by $20.7 million, or 21%, to $120.5 million for the three months ended December 28, 2025, driven by approximately $19 million from acquired businesses[75]. - Water Treatment segment sales for the nine months ended December 28, 2025, increased by $79.5 million, or 23%, to $421.0 million, with approximately $70 million from acquired businesses[89]. - Industrial Solutions segment sales increased by $11.3 million, or 7%, to $164.7 million for the nine months ended December 28, 2025[91]. - Food & Health Sciences segment sales decreased by $7.7 million, or 10%, to $70.0 million for the three months ended December 28, 2025, primarily due to decreased volumes[76]. Profitability - Gross profit for the three months ended December 28, 2025, increased by $2.4 million, or 5%, to $50.8 million, representing 21% of sales[79]. - Gross profit increased by $17.5 million, or 10%, to $190.8 million, representing 23% of sales for the nine months ended December 28, 2025[92]. - Water Treatment segment gross profit rose by $19.6 million, or 20%, to $116.6 million, maintaining 28% of sales for the same period[93]. - Food & Health Sciences segment gross profit decreased by $3.6 million, or 7%, to $48.7 million, accounting for 21% of sales[94]. - Operating income for the three months ended December 28, 2025, increased by $1.5 million, or 7%, to $22.6 million, or 9% of sales[84]. - Operating income increased by $3.2 million, or 3%, to $97.8 million, which is 12% of sales[97]. Expenses and Interest - SG&A expenses increased by $14.3 million, or 18%, to $93.0 million, representing 11% of sales[96]. - Interest expense increased to $3.4 million for the three months ended December 28, 2025, compared to $1.2 million in the same period a year ago, due to increased borrowings[85]. - Interest expense rose by $6.6 million to $10.5 million due to increased borrowings for the acquisition of WaterSurplus[98]. Cash Flow - Cash provided by operating activities was $106.6 million, up from $80.3 million in the same period last year[102]. - Cash used in investing activities was $204.6 million, including $167.1 million for acquisitions, primarily WaterSurplus[103]. - Cash provided by financing activities was $101.1 million, with net debt borrowings of $115.0 million[104]. - The effective interest rate on borrowings was 4.8% as of December 28, 2025[109]. Segment Reporting - The company realigned its reporting segments to Water Treatment, Food & Health Sciences, and Industrial Solutions to better reflect its operations[69].

Revenue Performance - Fourth quarter 2025 sales reached $373.2 million, a 7.9% increase year-over-year, with a 7.1% increase in constant currency[5] - Full-year 2025 sales totaled $1,374.7 million, reflecting a 5.2% year-over-year increase as reported and a 5.1% increase in constant currency[5] - Domestic revenue for Q4 2025 increased by 1.4% year-over-year, while international revenue rose by 17.0% as reported and 15.4% in constant currency[5] - The company expects full-year 2026 revenue to be between $1.345 billion and $1.375 billion, indicating organic constant currency growth of approximately 4.5% to 6% over 2025[4] Earnings and Profitability - Adjusted diluted net earnings per share for Q4 2025 were $1.43, compared to $1.34 in Q4 2024, while GAAP diluted net earnings per share were $0.54, down from $1.08 in Q4 2024[5] - For full-year 2026, the company anticipates adjusted diluted net earnings per share in the range of $4.30 to $4.45, including a currency tailwind of approximately $0.10[5] - The company reported a net income of $16.7 million for Q4 2025, down from $33.8 million in Q4 2024[9] - Adjusted net income for the year ended December 31, 2025, was $143.081 million, with diluted EPS of $4.59, up from $41.840 million and $1.34 in 2024[19] - The company reported a net income of $47.055 million for the year ended December 31, 2025, compared to $33.754 million in 2024[19] - The company reported a net income of $47,055,000 for the year ended December 31, 2025, down from $132,423,000 in 2024[28] Cost and Expenses - Gross profit margin for Q4 2025 was 58.5%, up from 57.3% in Q4 2024, while the full-year gross profit margin was 54.6%, compared to 56.1% in 2024[9] - Selling and administrative expenses for Q4 2025 were $166.764 million, or 44.7% of sales, compared to $132.669 million and 38.3% in Q4 2024[13] - The company incurred operational optimization costs of $12.450 million in 2025, impacting overall profitability[19] - The effective tax rate for Q4 2025 was 42.8%, compared to 22.7% in Q4 2024, indicating a significant increase in tax obligations[13] - The company faced legal matters costs of $2.609 million in 2025, impacting overall financial performance[19] - Costs related to operational optimization and compliance with EU Medical Device Regulations were incurred, impacting selling and administrative expenses[23][25] Research and Development - Research and development expenses for Q4 2025 were $14.9 million, compared to $13.2 million in Q4 2024, indicating a focus on innovation[9] - Research and development expenses for the year ended December 31, 2025, totaled $55.884 million, reflecting ongoing investment in innovation[19] - The company incurred $54,426,000 in research and development expenses, which accounted for 4.2% of sales[20] Strategic Focus - The company remains focused on key growth drivers in minimally invasive surgery, smoke evacuation, and orthopedic soft tissue repair as part of its strategic initiatives[4] - The company is focused on improving manufacturing operations and optimizing its operational processes through consulting engagements[21] Other Financial Adjustments - The company recorded a contingent consideration fair value adjustment of $(19.446) million in Q4 2025, affecting net income[13] - The company recognized a gain on the sale of a product line in 2025, contributing positively to its financial performance[24] - The company wrote off inventory and equipment related to the cancellation of planned new product lines, affecting cost of goods sold[22]

Financial Performance - Record net income of $7.4 million for Q4 2025, or $0.51 per diluted share, an increase from $4.3 million in Q3 2025 [21] - Adjusted net income for the year ended December 31, 2025 was $24.1 million, or $1.66 adjusted diluted earnings per share, compared to $18.6 million, or $1.39 per diluted share in 2024 [2] - Net revenue for Q4 2025 totaled $20.7 million, a 2.7% increase from Q3 2025 and an 18.0% increase from Q4 2024 [18] - Net income for Q4 2025 was $7.396 million, representing a 72.5% increase compared to $4.308 million in Q3 2025 [60] - Adjusted diluted earnings per share excluding unusual items for the year ended December 31, 2025, was $1.66, up from $1.41 in the previous year, representing a growth of 17.7% [66] Asset and Liability Management - Total assets increased 4.5% to $1.4 billion as of December 31, 2025, up 21.1% from $1.1 billion a year earlier [23] - Total liabilities increased to $1,193,736,000, a 4.4% increase from the previous quarter and a 21.6% increase year-over-year [58] - Total assets increased to $1,336 billion in Q4 2025, compared to $1.248 billion in Q3 2025 [61] - Total deposits reached $1.1 billion, an increase of $50.5 million from September 30, 2025, and up $207.6 million from $935.1 million a year earlier [27] - Total deposits rose to $1,142,695,000, marking a 4.6% increase from the previous quarter and a 22.2% increase year-over-year [58] Loan and Credit Quality - Total loans, net of deferred fees and costs, were $959.3 million as of December 31, 2025, an increase of $143.3 million from the previous year [24] - The allowance for credit losses was $9.9 million as of December 31, 2025, representing 1.03% of total loans [25] - The Company recorded a reversal for credit losses on loans of $130 thousand in Q4 2025, compared to $2.2 million provision expense in Q3 2025 [15] - The ratio of non-performing assets to total assets was 2.75% as of December 31, 2025, a decrease from 2.88% in the previous quarter but an increase from 1.26% a year ago [34] - The allowance for credit losses (ACL) was $10,577 thousand, representing 1.12% of total loans, consistent with the previous quarter's ratio [64] Income Sources - Non-interest income was $7.3 million for Q4 2025, compared to $5.8 million for Q4 2024, driven by increased credit card transaction volume [17] - Total interest income for Q4 2025 reached $22.739 million, an increase of 5.2% from $21.622 million in Q3 2025 [60] - Net interest income after provision for credit losses was $13.637 million, up 26.5% from $10.779 million in Q3 2025 [60] - Non-interest income totaled $7.263 million, a slight increase from $7.177 million in Q3 2025 [60] Growth Metrics - SBA loan originations reached a record $576.0 million for the year, up from $501.9 million in 2024, indicating strong growth potential [8] - SBA loan originations totaled $126.4 million in Q4 2025, down from a record $242.1 million in Q3 2025 but up from $120.0 million in Q4 2024 [39] - The company reported a significant increase in consumer loans, which rose by 563.0% year-over-year to $11,358,000 [58] Efficiency and Profitability - Return on average assets was 2.20% for Q4 2025, compared to 1.37% for Q3 2025, and return on average stockholders' equity was 18.03% compared to 10.89% for Q3 2025 [6] - The efficiency ratio for Q4 2025 was 61.05%, an increase from 55.31% in Q3 2025, suggesting higher operational costs relative to revenue [64] - The average yield on earning assets decreased to 7.20% in 2025 from 7.80% in 2024, while the cost on interest-bearing liabilities also decreased to 4.04% from 4.46% [62] Shareholder Value - Stockholders' equity increased to $165.8 million as of December 31, 2025, compared to $158.2 million in the prior quarter and $140.7 million a year earlier, driven by retained earnings from net income [31] - Book value per common share increased to $11.52 in Q4 2025 from $11.07 in Q3 2025, reflecting a positive trend in shareholder equity [64]

Table of Contents For the quarterly period ended December 27, 2025 or UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____to _____ Commission File Number 001-36801 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) D ...

RAYMOND JAMES FINANCIAL REPORTS FISCAL FIRST QUARTER OF 2026 RESULTS ST. PETERSBURG, Fla. – Raymond James Financial, Inc. (NYSE: RJF) today reported net revenues of $3.74 billion and net income available to common shareholders of $562 million, or $2.79 per diluted share, for the fiscal first quarter ended December 31, 2025. Excluding $15 million of expenses, net of tax, related to acquisitions, quarterly adjusted net income available to common shareholders was $577 million , or $2.86 per diluted share . (1) ...

ServiceNow Reports Fourth Quarter and Full-Year 2025 Financial Results; Board of Directors Authorizes Additional $5B for Share Repurchase Program Recent Business Highlights Partner Updates SANTA CLARA, Calif. - January 28, 2026 - ServiceNow (NYSE: NOW), the AI control tower for business reinvention, today announced financial results for its fourth quarter ended December 31, 2025, with subscription revenues of $3,466 million in Q4 2025, representing 21% year-over-year growth and 19.5% in constant currency. " ...